Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 25 September 2008, doi:10.1136/bmj.a1472
Cite this as: BMJ 2008;337:a1472
Can improve outcomes alongside other standard interventions
| The first 150 words of the full text of this article appear below. |
The diagnosis and management of diabetes that presents during pregnancy has always been difficult. Women are usually asymptomatic and are not aware that the condition may occur for the first time during pregnancy. The prevalence varies from 1.4% to 14% depending on the population.1 Women who are first found to have abnormal glucose concentrations during pregnancy form a heterogeneous group, which includes women with unrecognised pre-existing type 2 diabetes and small numbers of women with unrecognised type 1 diabetes.2 Once the diagnosis of diabetes is established in a pregnant woman, blood glucose concentrations should be controlled to decrease the risk of maternal and neonatal complications.
The linked randomised controlled trial by Murphy and colleagues (doi:10.1136/bmj.a1680) compares the effects of standard antenatal care with and without continuous glucose monitoring in 71 women with type 1 or type 2 diabetes. Continuous glucose monitoring was used as an educational tool to
Mario R Festin, professor
1 Obstetrics and Gynecology, College of Medicine, University of the Philippines, Ermita, Manila, Philippines
mfestinmd@yahoo.com
Read all Rapid Responses